У нас вы можете посмотреть бесплатно Expert Talk - Your DSCSA Toolbox: VRS, Credentials & Interoperability или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
FDA’s DSCSA deadlines are here - and the pressure is on for manufacturers, wholesalers and dispensers to achieve compliance with secure, interoperable systems. The good news? Meeting these requirements doesn’t have to be complicated or expensive. Join experts from Spherity, Criterion Consulting and Movilitas.Cloud as we break down today’s DSCSA challenges, focusing on Verification Router Service (VRS) and Authorized Trading Partner (ATP) status checks. Discover how to equip your business with our free DSCSA app and see how these solutions connect seamlessly across your supply chain. What you’ll learn: ➕ Common DSCSA challenges faced by trading partners ➕ How to overcome issues with VRS ➕ How to use the Movilitas.Cloud app to verify products instantly ➕ How Spherity credentials strengthen compliance and interoperability Take the guesswork and cost out of DSCSA compliance. Walk away with a clear understanding - and the free tools - you need to get started today. Want to know more? 💬 Click here for more information: https://www.movilitas.cloud/industrie... 🤝 Contact Marc Blekkink (Movilitas.Cloud) on LinkedIn to schedule a 1:1 discussion In this Expert Talk: 00:00 Welcome & Speakers 00:44 Why This Webinar & Partner Roles 01:27 DSCSA Final Countdown & Deadlines 05:12 TI/TS, EPCIS & Real-World Exceptions 12:00 Get Compliant Fast with Movilitas.Cloud 14:11 Why Start Now: Resources & Integration Reality 15:18 Inside VRS: Routing & Sub-Second Answers 18:23 ATP Credentials vs GLNs (Identity & Trust) 24:23 Free DSCSA App: Credentials & Scanning Flow 26:27 Key Takeaways & Q&A Highlights